Close Menu

NEW YORK (GenomeWeb) – German molecular diagnostics firm New Oncology today announced a collaboration with the University Hospital Oslo aimed at guiding treatment of patients with targeted cancer therapies.

Financial details of the agreement weren't disclosed, but New Oncology, the molecular diagnostics division of genomic analytics firm Blackfield, said that under the collaboration it will use its next-gen sequencing diagnostic platform, Neo, to identify alterations in cancer-related genes that predict a patient's response or resistance to targeted therapies.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.